| |
| |
|
| Insider
Information: |
Leff Jonathan S |
| Relationship: |
Director, 10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
77,251 |
|
|
Indirect Shares
|
34,034,246 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$3,163,505 |
|
|
| Total
Shares |
34,111,497 |
|
|
| Total
Value |
$3,163,505 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
InterMune Inc |
ITMN |
Director |
2013-02-28 |
77,251 |
2011-06-07 |
16,481 |
Premium* |
|
|
Allos Therapeutics Inc |
ALTH |
Director |
2012-09-04 |
0 |
2008-05-29 |
26,124,430 |
Premium* |
|
|
Viracta Therapeutics Ord Shs |
VIRX |
Director |
2005-09-30 |
0 |
2007-09-28 |
4,304,089 |
Premium* |
|
|
Altus Pharmaceuticals Inc. |
ALTUQ |
Director, 10% Owner |
2006-01-31 |
0 |
2006-01-31 |
3,589,246 |
Premium* |
|
|
Zymogenetics Inc |
ZGEN |
Director, 10% Owner |
2007-09-11 |
0 |
2010-10-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
63 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • • |
2005-09-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
20 |
|
- |
|
| ALTH |
Allos Therapeutics Inc |
Director |
– • – |
2005-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
22,624,430 |
22,624,430 |
|
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • • |
2005-09-30 |
4 |
A |
$0.00 |
$0 |
I/I |
2,376,722 |
934,127 |
|
- |
|
| ALTUQ |
Altus Pharmaceuticals Inc... |
officerTitle |
– • • |
2006-01-31 |
4 |
A |
$0.00 |
$0 |
I/I |
3,589,246 |
3,589,246 |
|
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2007-09-28 |
5 |
A |
$0.00 |
$0 |
I/I |
10 |
4,304,089 |
0 |
- |
|
| ITMN |
InterMune Inc |
Director |
– • – |
2011-05-11 |
4 |
D |
$0.00 |
$0 |
I/I |
(4,999,993) |
4,485,216 |
0 |
- |
|
| ITMN |
InterMune Inc |
Director |
– • – |
2011-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
21,008 |
21,008 |
0 |
- |
|
| ITMN |
InterMune Inc |
Director |
– • – |
2011-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
18,718 |
79,726 |
0 |
- |
|
| ITMN |
InterMune Inc |
Director |
– • – |
2011-06-07 |
4 |
D |
$0.00 |
$0 |
I/I |
(4,468,735) |
16,481 |
0 |
- |
|
| ALTH |
Allos Therapeutics Inc |
Director |
– • – |
2011-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
55,000 |
55,000 |
0 |
- |
|
| ALTH |
Allos Therapeutics Inc |
Director |
• • – |
2012-09-04 |
4 |
D |
$1.82 |
$100,100 |
D/D |
(55,000) |
0 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2007-05-30 |
4 |
B |
$4.43 |
$2,999,996 |
I/I |
677,200 |
4,304,075 |
2.1 |
- |
|
| ITMN |
InterMune Inc |
Director |
– • – |
2010-01-26 |
4 |
OE |
$4.50 |
$180,000 |
D/D |
40,000 |
9,525,209 |
0 |
- |
|
| ALTH |
Allos Therapeutics Inc |
Director |
– • – |
2008-05-29 |
4 |
B |
$5.64 |
$19,740,000 |
I/I |
3,500,000 |
26,124,430 |
2.1 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • • |
2006-03-17 |
4 |
B |
$6.21 |
$5,000,000 |
I/I |
805,153 |
3,626,875 |
2.25 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • • |
2005-09-30 |
4 |
B |
$7.00 |
$3,115,000 |
I/I |
445,000 |
1,379,127 |
2.25 |
- |
|
| ZGEN |
Zymogenetics Inc |
Director |
– • – |
2008-03-07 |
4 |
B |
$8.51 |
$488,791 |
I/I |
56,722 |
9,077,471 |
2.1 |
- |
|
| ITMN |
InterMune Inc |
Director |
– • – |
2013-02-28 |
4 |
D |
$8.79 |
$62,479 |
D/D |
(7,108) |
77,251 |
0 |
- |
|
| ZGEN |
Zymogenetics Inc |
Director |
– • – |
2008-02-21 |
4 |
B |
$9.02 |
$883,096 |
I/I |
96,570 |
7,897,090 |
2.1 |
- |
|
| ZGEN |
Zymogenetics Inc |
Director |
– • – |
2008-03-05 |
4 |
B |
$9.17 |
$917,178 |
I/I |
98,254 |
8,840,267 |
2.1 |
- |
|
| ZGEN |
Zymogenetics Inc |
Director |
– • – |
2008-02-25 |
4 |
B |
$9.40 |
$1,392,950 |
I/I |
145,000 |
8,269,520 |
2.1 |
- |
|
| ZGEN |
Zymogenetics Inc |
Director |
– • – |
2008-02-26 |
4 |
B |
$9.45 |
$17,994 |
I/I |
1,900 |
8,271,420 |
2.1 |
- |
|
| ZGEN |
Zymogenetics Inc |
Director |
– • – |
2008-03-03 |
4 |
B |
$9.49 |
$1,341,887 |
I/I |
139,536 |
8,541,549 |
2.1 |
- |
|
| ZGEN |
Zymogenetics Inc |
Director |
– • • |
2010-10-07 |
4 |
D |
$9.75 |
$91,528,700 |
I/I |
(9,387,559) |
0 |
0 |
- |
|
| ZGEN |
Zymogenetics Inc |
Director |
– • – |
2008-02-28 |
4 |
B |
$9.85 |
$100,991 |
I/I |
10,142 |
8,309,004 |
2.1 |
- |
|
63 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
